within Pharmacolibrary.Drugs.ATC.R;

model R06AX09
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.4,
    Cl             = 0.0016666666666666668,
    adminDuration  = 600,
    adminMass      = 1 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.003,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0008333333333333334,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>R06AX09</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Azatadine is a first-generation antihistamine, formerly used for the symptomatic relief of allergic reactions and rhinitis. It acts as an H1 receptor antagonist and was widely prescribed for allergy symptoms but is largely discontinued and unavailable in many countries due to adverse effect profile and the advent of newer, safer agents.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for adult oral administration, as no published human PK studies with full modeled parameters available.</p><h4>References</h4><ol><li><p>Mann, KV, et al., &amp; Tietze, KJ (1989). Nonsedating histamine H1-receptor antagonists. <i>Clinical pharmacy</i> 8(5) 331–344. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/2568212/\">https://pubmed.ncbi.nlm.nih.gov/2568212</a></p></li><li><p>Simons, FE, et al., &amp; Yeh, J (1987). The comparative pharmacokinetics of H1-receptor antagonists. <i>Annals of allergy</i> 59(6 Pt 2) 20–24. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/2892445/\">https://pubmed.ncbi.nlm.nih.gov/2892445</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end R06AX09;
